Clinical Trials Browser

INDUSTRY × Observational × durvalumab × Clear all

NCT06117891 2026-05-12

REFINE-IO

Active not recruiting

Gastrointestinal

Unresectable Hepatocellular Carcinoma

NCT05683977 2026-02-24

ARSENAL

Active not recruiting

Small Cell Lung Carcinoma

NCT06252753 2025-12-26

LIVER-R

Gastrointestinal

Hepatobiliary Cancers

NCT06826677 2025-06-24

ARAL

Small Cell Lung Carcinoma

NCT04667312 2023-10-02

CODAK

Non-Small Cell Lung Cancer NSCLC

NCT05933044 2023-09-05

RELEVANCE

Carcinoma, Non-Small-Cell Lung